Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tuberculosis Active”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00767975
What this trial is testing

Active Screening of Latent TB Infection, Treatment and Long Term Follow-up in Prison

Who this might be right for
Tuberculosis
National Taiwan University Hospital 2,384
Not applicableLooking for participantsNCT06033807
What this trial is testing

Active Screening of Latent Tuberculosis Infection in School Contacts of Active Tuberculosis Patients

Who this might be right for
TuberculosisLatent Tuberculosis Infection
Huashan Hospital 31,440
Not applicableLooking for participantsNCT06590428
What this trial is testing

Therapeutic Drug Monitoring for Linezolid in the Treatment of Rifampin-resistant Tuberculosis

Who this might be right for
Rifampin-resistant TuberculosisDrug-resistant Tuberculosis
Albert Einstein College of Medicine 280
Large-scale testing (Phase 3)Study completedNCT00170209
What this trial is testing

Rifampin Versus Isoniazid for the Treatment of Latent Tuberculosis Infection in Children (P4v9)

Who this might be right for
Latent Tuberculosis Infection
McGill University 844
Early research (Phase 1)Study completedNCT02393586
What this trial is testing

Whole Blood Bactericidal Activity (WBA) Against Mycobacterium Tuberculosis of Faropenem Plus Amoxicillin/Clavulanic Acid in Healthy Volunteers

Who this might be right for
Tuberculosis
National University Hospital, Singapore 43
Early research (Phase 1)Study completedNCT02700347
What this trial is testing

Whole Blood Bactericidal Activity Against Mycobacterium Tuberculosis of Pyrazinamide Plus Allopurinol in Healthy Volunteers

Who this might be right for
Tuberculosis
National University Hospital, Singapore 12
Not applicableUnknownNCT02512484
What this trial is testing

Improving the Detection of Active Tuberculosis in Accident and Emergency Departments

Who this might be right for
Latent TuberculosisActive Tuberculosis
Public Health England 1,000
Large-scale testing (Phase 3)Study completedNCT01404312
What this trial is testing

Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)

Who this might be right for
TuberculosisHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 3,000
Testing effectiveness (Phase 2)Study completedNCT03557281
What this trial is testing

An Early Bactericidal Activity, Safety and Tolerability of GSK3036656 in Subjects With Drug-sensitive Pulmonary Tuberculosis

Who this might be right for
Tuberculosis
GlaxoSmithKline 76
Not applicableWithdrawnNCT00788320
What this trial is testing

Vitamin D in Active Tuberculosis (TB) Study

Who this might be right for
Tuberculosis
Atlanta VA Medical Center
Large-scale testing (Phase 3)Looking for participantsNCT06022146
What this trial is testing

A Novel Therapy With a 1-Month Ultrashort Regimen to Halt Progression From Latent Infection to Active Tuberculosis Among Close Contacts (The TB-YOUTH Study)

Who this might be right for
TuberculosisLatent Tuberculosis
Huashan Hospital 3,520
Not applicableNot Yet RecruitingNCT07687121
What this trial is testing

Shaping a Community-based Pathway to Improve TB Surveillance Among African and Hindustan Immigrants Experiencing Vulnerabilities

Who this might be right for
TuberculosisTuberculosis (TB)Tuberculosis Active+1 more
Universidade Nova de Lisboa 200
Testing effectiveness (Phase 2)Study completedNCT00822315
What this trial is testing

Efficacy and Safety of 2 Raltegravir Doses in Naive HIV-1-infected Patients Receiving Rifampin for Active Tuberculosis

Who this might be right for
HIV InfectionsTuberculosis
ANRS, Emerging Infectious Diseases 155
Early research (Phase 1)Study completedNCT05537038
What this trial is testing

Safety and Immune Responses After Vaccination With Two Investigational RNA-based Vaccines Against Tuberculosis in Healthy Volunteers

Who this might be right for
Tuberculosis
BioNTech SE 120
Not applicableStudy completedNCT03187964
What this trial is testing

Xpert Ultra and Xpert HIV-VL in People Living With HIV

Who this might be right for
HIV/AIDSTB - TuberculosisAntiretroviral Therapy, Highly Active
University of Stellenbosch 1,053
Large-scale testing (Phase 3)UnknownNCT02897180
What this trial is testing

Efficacy of Nyaditum Resae(R) Against Active TB in Georgia

Who this might be right for
Close Contacts of Active Tuberculosis
Fundació Institut Germans Trias i Pujol 3,300
Not applicableStudy completedNCT03832023
What this trial is testing

Community-based Tuberculosis Tracing and Preventive Therapy

Who this might be right for
Tuberculosis
Elizabeth Glaser Pediatric AIDS Foundation 1,400
Testing effectiveness (Phase 2)Study completedNCT04176250
What this trial is testing

Early Bactericidal Activity of TBA-7371 in Pulmonary Tuberculosis

Who this might be right for
Pulmonary Tuberculosis
Gates Medical Research Institute 93
Not applicableStudy completedNCT03973970
What this trial is testing

Assessing the Ability of the T-SPOT®.TB Test (IQ)

Who this might be right for
Tuberculosis
Oxford Immunotec 201
Not applicableUnknownNCT02174380
What this trial is testing

Effectiveness of Active Case Finding of Household Contacts in a Routine Tuberculosis (TB) Control Program

Who this might be right for
Tuberculosis
Lena Shah 1,900
Next Page